OGEDA SA
Patent Owner
Stats
- 35 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Mar 08, 2018 most recent publication
Details
- 35 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 232 Total Citation Count
- Apr 09, 1997 Earliest Filing
- 0 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0298,070 NOVEL CHIRAL SYNTHESIS OF N-ACYL-(3-SUBSTITUTED)-(8-SUBSTITUTED)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINESSep 25, 15Oct 19, 17[C07D]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9840508 N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a] pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disordersMar 28, 14Dec 12, 17[C07D]
9770435 Compounds, pharmaceutical composition and methods for use in treating inflammatory diseasesNov 27, 14Sep 26, 17[A61K, C07D]
9695120 Substituted pyrrolidines as G-protein coupled receptor 43 agonistsJun 18, 12Jul 04, 17[A61K, C07D]
9475814 -acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereofOct 03, 12Oct 25, 16[C07D]
9422299 Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonistsApr 23, 15Aug 23, 16[A61K, C07D]
8871761 NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disordersSep 26, 12Oct 28, 14[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
- No Patents to Display
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.